Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

PRP and cell therapies may help with hair loss, but more research is needed.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Lupus patients' body image issues significantly affect their mental health and need more support.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

Possible link between androgens and COVID-19 severity; more research needed.

Low-dose oral minoxidil is an effective and well-tolerated treatment for hair growth in alopecia patients.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Effective symptom management in IBD improves quality of life and prevents complications.